Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Effect of reduced dietary fat on estradiol, adiponectin, and IGF-1 levels in postmenopausal women with breast cancer.

Murillo-Ortiz B, Martínez-Garza S, Cárdenas Landeros V, Cano Velázquez G, Suárez García D.

Breast Cancer (Dove Med Press). 2017 May 23;9:359-364. doi: 10.2147/BCTT.S132602. eCollection 2017.

2.

The effect of lipoaspirates vs. dissected abdominal fat on breast cancer cells in vitro.

Almarzouqi F, Rennekampff HO, Stromps JP, Alharbi Z, Pallua N.

Eur J Med Res. 2017 Mar 21;22(1):10. doi: 10.1186/s40001-017-0251-3.

3.

Association of plasma adiponectin and leptin levels with the development and progression of ovarian cancer.

Jin JH, Kim HJ, Kim CY, Kim YH, Ju W, Kim SC.

Obstet Gynecol Sci. 2016 Jul;59(4):279-85. doi: 10.5468/ogs.2016.59.4.279. Epub 2016 Jul 13.

4.

Endothelial progenitor cells promote tumor growth and progression by enhancing new vessel formation.

Zhao X, Liu HQ, Li J, Liu XL.

Oncol Lett. 2016 Aug;12(2):793-799. Epub 2016 Jun 15.

5.
6.

Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk.

Stern JH, Rutkowski JM, Scherer PE.

Cell Metab. 2016 May 10;23(5):770-84. doi: 10.1016/j.cmet.2016.04.011. Review.

7.

Adiponectin-Mediated Analgesia and Anti-Inflammatory Effects in Rat.

Iannitti T, Graham A, Dolan S.

PLoS One. 2015 Sep 9;10(9):e0136819. doi: 10.1371/journal.pone.0136819. eCollection 2015.

8.

Cross-Talk between Adiponectin and IGF-IR in Breast Cancer.

Mauro L, Naimo GD, Ricchio E, Panno ML, Andò S.

Front Oncol. 2015 Jul 15;5:157. doi: 10.3389/fonc.2015.00157. eCollection 2015. Review.

9.

A Prospective Analysis of Plasma Adiponectin and Risk of Incident Cancer: The Dallas Heart Study.

Beg MS, Saleem S, Turer A, Ayers C, de Lemos JA, Khera A, Scherer PE, Lakoski SG.

J Natl Compr Canc Netw. 2015 Jul;13(7):873-8.

10.

Adiponectin fine-tuning of liver regeneration dynamics revealed through cellular network modelling.

Correnti JM, Cook D, Aksamitiene E, Swarup A, Ogunnaike B, Vadigepalli R, Hoek JB.

J Physiol. 2015 Jan 15;593(2):365-83. doi: 10.1113/jphysiol.2014.284109.

11.

Obesity and cancer--mechanisms underlying tumour progression and recurrence.

Park J, Morley TS, Kim M, Clegg DJ, Scherer PE.

Nat Rev Endocrinol. 2014 Aug;10(8):455-65. doi: 10.1038/nrendo.2014.94. Epub 2014 Jun 17. Review.

12.

The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer.

Hollern DP, Honeysett J, Cardiff RD, Andrechek ER.

Mol Cell Biol. 2014 Sep;34(17):3229-43. doi: 10.1128/MCB.00737-14. Epub 2014 Jun 16.

13.

Linking adiponectin and autophagy in the regulation of breast cancer metastasis.

Libby EF, Frost AR, Demark-Wahnefried W, Hurst DR.

J Mol Med (Berl). 2014 Oct;92(10):1015-23. doi: 10.1007/s00109-014-1179-5. Epub 2014 Jun 7. Review.

14.

Obesity, inflammation, and lung injury (OILI): the good.

Wang C.

Mediators Inflamm. 2014;2014:978463. doi: 10.1155/2014/978463. Epub 2014 May 11. Review.

15.

Protein kinase C Beta in the tumor microenvironment promotes mammary tumorigenesis.

Wallace JA, Pitarresi JR, Sharma N, Palettas M, Cuitiño MC, Sizemore ST, Yu L, Sanderlin A, Rosol TJ, Mehta KD, Sizemore GM, Ostrowski MC.

Front Oncol. 2014 Apr 23;4:87. doi: 10.3389/fonc.2014.00087. eCollection 2014.

16.

Cardiometabolic effects of adiponectin.

Parker-Duffen JL, Walsh K.

Best Pract Res Clin Endocrinol Metab. 2014 Jan;28(1):81-91. doi: 10.1016/j.beem.2013.09.001. Epub 2013 Sep 13. Review.

17.

Multifaceted roles of adiponectin in cancer.

Hebbard L, Ranscht B.

Best Pract Res Clin Endocrinol Metab. 2014 Jan;28(1):59-69. doi: 10.1016/j.beem.2013.11.005. Epub 2013 Nov 22. Review.

18.

Serum leptin, adiponectin and endometrial cancer risk in Chinese women.

Ma Y, Liu Z, Zhang Y, Lu B.

J Gynecol Oncol. 2013 Oct;24(4):336-41. doi: 10.3802/jgo.2013.24.4.336. Epub 2013 Oct 2.

19.

Cholesterol-induced mammary tumorigenesis is enhanced by adiponectin deficiency: role of LDL receptor upregulation.

Liu J, Xu A, Lam KS, Wong NS, Chen J, Shepherd PR, Wang Y.

Oncotarget. 2013 Oct;4(10):1804-18.

20.

Adiponectin, driver or passenger on the road to insulin sensitivity?

Ye R, Scherer PE.

Mol Metab. 2013 Apr 19;2(3):133-41. doi: 10.1016/j.molmet.2013.04.001. Review.

Supplemental Content

Support Center